Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker NTLA
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 10, 2026 | 12790624 Methods of genotyping adeno-associated virus inverted terminal repeat… | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Nov 3, 2026 | 12781209 Compositions and methods for kallikrein (KLKB1) gene editing | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 15, 2026 | 12735698 Modified guide RNAs | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Jul 21, 2026 | 12686876 Compositions and methods comprising a TTR guide RNA and a polynucleot… | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Jul 7, 2026 | 12674151 Compositions and methods for kallikrein (KLKB1) gene editing | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| May 19, 2026 | 12630820 Compositions and methods for immunotherapy | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Feb 24, 2026 | 12559748 Compositions and methods for the treatment of hemoglobinopathies | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Nov 25, 2025 | 12480109 Compositions and methods for kallikrein (KLKB1) gene editing | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Nov 4, 2025 | 12460205 Compositions and methods for treating alpha-1 antitrypsin deficiency | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Aug 19, 2025 | 12391722 Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA) | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Feb 4, 2025 | 12214023 Compositions and methods for expressing factor IX | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 24, 2024 | 12173284 Modified guide RNAs | NTLA Intellia Therapeutics, Inc. | utility | Google Patents ↗ |
12 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:17 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances